[Collaborator's Work] Ribociclib plus Endocrine Therapy in MONALEESA-7: Updated OS Data
- OOTR
- Jun 24, 2022
- 1 min read
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial
by Yen-Shen Lu, Seock Ah-Im, Louis Chow, and colleagues
Click the link below to read more:
Comments